MALVERN PANALYTICAL LIMITED

Their core work

Malvern Panalytical is a major scientific instruments company specializing in particle characterization, spectroscopy, and analytical measurement technologies. In H2020 projects, they contribute their proprietary instrumentation and expertise in nanoparticle sizing, process analytical technology (PAT), and molecular biophysics measurements. Their role is typically to provide advanced characterization tools and methods that other consortium partners rely on for quality control, environmental fate studies, and drug delivery research. They bridge the gap between laboratory-grade analytical science and real-world industrial process monitoring.

What they specialise in

How they've shifted over time

Their early H2020 work (2015–2018) centered on environmental nano-safety — characterizing how nanoparticles behave in the environment and establishing standardized measurement protocols (NanoFASE, ACEnano). From 2019 onward, the focus shifted decisively toward applied industrial and biomedical uses: real-time process control for nanoparticle manufacturing (PAT4Nano), RNA therapeutic delivery systems (B-SMART), and biophysics research infrastructure (MOSBRI). This evolution mirrors the broader transition in European nano-research from "is it safe?" to "how do we manufacture and use it?"

Malvern Panalytical is moving from environmental characterization toward real-time manufacturing analytics and biopharma applications, making them increasingly relevant for drug delivery and Industry 4.0 consortia.

How they like to work

Malvern Panalytical participates exclusively as a partner, never as coordinator — consistent with their role as an instrumentation provider embedded in research-led consortia. With 90 unique partners across 20 countries in just 5 projects, they operate in large, international consortia (averaging 18+ partners per project). This broad network suggests they are a trusted, go-to measurement partner that multiple research groups want in their proposals for credibility and instrument access.

Exceptionally broad network for their project count: 90 unique partners across 20 countries from only 5 projects. This pan-European reach reflects their status as a sought-after instrumentation partner in large multi-national consortia.

What sets them apart

As a large commercial instruments manufacturer, Malvern Panalytical offers something most consortium partners cannot: proprietary, industrially validated measurement technologies that can move from lab research to production-line deployment. Their participation de-risks the "measurement gap" in projects — ensuring that what gets characterized in the lab can also be monitored at industrial scale. For consortium builders, having them on board signals both technical credibility and a pathway to commercial instrumentation adoption.

Highlights from their portfolio

• PAT4Nano
  Their largest H2020 investment (EUR 845K) and most strategically aligned project — directly focused on translating their core particle sizing technology into real-time industrial process control.
• B-SMART
  Demonstrates their expansion into biopharma: characterizing RNA-loaded nanocarriers for neurodegenerative disease treatment, a high-growth application area for their instruments.
• ACEnano
  Positioned them at the center of European nanomaterial characterization standards — building tiered assessment frameworks that reference their measurement approaches.